148 related articles for article (PubMed ID: 34756586)
1. Molecular testing results as a quality metric for evaluating cytopathologists' utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirations.
VanderLaan PA; Nishino M
J Am Soc Cytopathol; 2022; 11(2):67-73. PubMed ID: 34756586
[TBL] [Abstract][Full Text] [Related]
2. Performance of Afirma genomic sequencing classifier and histopathological outcome are associated with patterns of atypia in Bethesda category III thyroid nodules.
Jin X; Lew M; Pantanowitz L; Smola B; Jing X
Cancer Cytopathol; 2022 Nov; 130(11):891-898. PubMed ID: 35789120
[TBL] [Abstract][Full Text] [Related]
3. Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with postoperative molecular testing.
Munoz-Zuluaga CA; Heymann JJ; Solomon JP; Patel A; Siddiqui MT; Scognamiglio T; Gokozan HN
Am J Clin Pathol; 2024 May; 161(5):463-468. PubMed ID: 38104250
[TBL] [Abstract][Full Text] [Related]
4. Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration.
Jin X; Lew M; Pantanowitz L; Iyengar JJ; Haymart MR; Papaleontiou M; Broome D; Sandouk Z; Raja SS; Hughes DT; Smola B; Jing X
Diagn Cytopathol; 2023 Nov; 51(11):698-704. PubMed ID: 37519144
[TBL] [Abstract][Full Text] [Related]
5. Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience.
Zhang L; Smola B; Lew M; Pang J; Cantley R; Pantanowitz L; Heider A; Jing X
Diagn Cytopathol; 2021 Aug; 49(8):921-927. PubMed ID: 34021740
[TBL] [Abstract][Full Text] [Related]
6. The frequency of 'atypia of undetermined significance' interpretations for thyroid fine-needle aspirations is negatively correlated with histologically proven malignant outcomes.
Vanderlaan PA; Krane JF; Cibas ES
Acta Cytol; 2011; 55(6):512-7. PubMed ID: 22156459
[TBL] [Abstract][Full Text] [Related]
7. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
[TBL] [Abstract][Full Text] [Related]
8. Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine-needle aspirates: A quality-assurance metric for evaluating diagnostic performance in a cytopathology laboratory.
Gokozan HN; Dilcher TL; Alperstein SA; Qiu Y; Mostyka M; Scognamiglio T; Solomon JP; Song W; Rennert H; Beg S; Stern E; Goyal A; Siddiqui MT; Heymann JJ
Cancer Cytopathol; 2022 Apr; 130(4):259-274. PubMed ID: 34962713
[TBL] [Abstract][Full Text] [Related]
9. Binary subclassification scheme (AUS-Nuclear versus AUS-Other) adequately risk-stratifies thyroid fine needle aspiration specimens classified as Atypia of Undetermined Significance.
Guzmán-Arocho YD; VanderLaan PA; Nishino M
J Am Soc Cytopathol; 2024; 13(1):23-32. PubMed ID: 37957061
[TBL] [Abstract][Full Text] [Related]
10. An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.
Kroll-Wheeler L; Cantley R; Pang JC; Soles BS; Smola B; Jing X; Lew M
Diagn Cytopathol; 2021 Jan; 49(1):31-38. PubMed ID: 32936526
[TBL] [Abstract][Full Text] [Related]
11. Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi-institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist.
Nacchio M; Palladino R; Vigliar E; Pisapia P; Salatiello M; Malapelle U; Porcelli T; Luongo C; Fonderico F; Masone S; Salvatore D; Troncone G; Bellevicine C
Cancer Cytopathol; 2023 Dec; 131(12):772-780. PubMed ID: 37635646
[TBL] [Abstract][Full Text] [Related]
12. Use of molecular testing results to analyze the overuse of atypia of undetermined significance in thyroid cytology.
Martinez Coconubo D; Levy JJ; Kerr DA; Vaickus LJ; Vidis L; Glass RE; Gutmann EJ; Marotti JD; Liu X
J Am Soc Cytopathol; 2023; 12(6):451-460. PubMed ID: 37775434
[TBL] [Abstract][Full Text] [Related]
13. UTILITY OF ULTRASOUND VERSUS GENE EXPRESSION CLASSIFIER IN THYROID NODULES WITH ATYPIA OF UNDETERMINED SIGNIFICANCE.
Villabona CV; Mohan V; Arce KM; Diacovo J; Aggarwal A; Betancourt J; Amer H; Jose T; DeSantis P; Cabral J
Endocr Pract; 2016 Oct; 22(10):1199-1203. PubMed ID: 27409819
[TBL] [Abstract][Full Text] [Related]
14. Performance of Afirma Gene Sequencing Classifier versus Gene Expression Classifier in thyroid nodules with indeterminate cytology.
Yang Z; Zhang T; Layfield L; Esebua M
J Am Soc Cytopathol; 2022; 11(2):74-78. PubMed ID: 34366280
[TBL] [Abstract][Full Text] [Related]
15. Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations: Follow-Up and Outcome Experience in Newfoundland, Canada.
Erivwo P; Ghosh C
Acta Cytol; 2018; 62(2):85-92. PubMed ID: 29486467
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience.
Wei S; Veloski C; Sharda P; Ehya H
Cancer Cytopathol; 2019 Nov; 127(11):720-724. PubMed ID: 31536167
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
Zhu QL; Faquin WC; Samir AE
AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
19. Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules.
Angell TE; Heller HT; Cibas ES; Barletta JA; Kim MI; Krane JF; Marqusee E
Thyroid; 2019 May; 29(5):650-656. PubMed ID: 30803388
[No Abstract] [Full Text] [Related]
20. Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance.
Mejia-Mejia O; Bravo-Gonzalez A; Sanchez-Avila M; Tjendra Y; Santoscoy R; Drews-Elger K; Zuo Y; Arias-Abad C; Gomez C; Garcia-Buitrago M; Nadji M; Jorda M; Velez-Torres JM; Ruiz-Cordero R
Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38594192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
